{"gene":"DRAP1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1996,"finding":"DRAP1 was isolated from HeLa cells as a Dr1-associated polypeptide that functions as a transcriptional corepressor. Corepressor function requires direct interaction between DRAP1 and Dr1 via a histone fold motif present at the amino terminus of both polypeptides. Association of DRAP1 with Dr1 increases stability of the Dr1-TBP-TATA motif complex and precludes entry of TFIIA and/or TFIIB into preinitiation complexes.","method":"Biochemical purification from HeLa cells, in vitro transcription assays, protein interaction studies, histone fold domain mutagenesis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — original biochemical reconstitution with in vitro transcription assays, domain mutagenesis, and isolation from native cells; foundational paper replicated by multiple subsequent studies","pmids":["8608938"],"is_preprint":false},{"year":1997,"finding":"The Dr1/DRAP1 heterodimer functions as a global repressor of RNA polymerase II transcription in vivo. Yeast orthologs YDR1 (Dr1) and BUR6 (DRAP1) are encoded by essential genes; the complex represses transcription by directly targeting TBP. Overexpression of Dr1 in vivo reduces mRNA accumulation and impairs cell growth, both effects reversible by TBP overexpression. The complex also represses RNA polymerase III but not RNA polymerase I transcripts.","method":"Yeast genetics (gene deletion, overexpression, rescue experiments), in vitro reconstituted Pol II transcription system, mRNA accumulation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and biochemical approaches in yeast, replicated in vitro; consistent with independent biochemical findings from multiple labs","pmids":["9023340"],"is_preprint":false},{"year":1997,"finding":"Functional dissection of the Dr1-DRAP1 complex showed that Dr1 contains a TBP-tethering domain and a separate glutamine-alanine-rich repression domain. DRAP1 enhancement of Dr1-mediated repression requires the Dr1 tethering domain; DRAP1 interaction with Dr1 lacking the tethering domain is not functional for repression. The repression domain of Dr1 directly and functionally interacts with TBP.","method":"Domain deletion mutagenesis, in vitro transcription assays, protein-protein interaction assays with recombinant proteins","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with domain mutagenesis, single lab but multiple orthogonal functional assays","pmids":["8972183"],"is_preprint":false},{"year":1997,"finding":"A defect in the yeast NC2 (Dr1×DRAP1) suppresses mutations in SRB4 (an RNA polymerase II holoenzyme component), establishing NC2 as a global negative regulator of class II transcription in vivo that functionally antagonizes the Pol II holoenzyme.","method":"Genetic suppressor screen, in vivo mRNA synthesis measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in yeast, single lab, two complementary genetic approaches","pmids":["9096360"],"is_preprint":false},{"year":1997,"finding":"The yeast BUR6 gene encodes a DRAP1/NC2alpha homolog. The histone fold domain of Bur6p is required for function in vivo; extensive deletion alleles throughout the histone fold domain impair function, whereas mutations in amino- and carboxy-terminal tails have no effect. BUR6 and BUR3/MOT1 have different functions depending on promoter context: both increase transcription from TATA-less UAS-deleted promoters but reduce transcription from the wild-type GAL1 and GAL10 promoters.","method":"Molecular cloning, deletion mutagenesis, in vivo transcription assays in yeast","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic domain mutagenesis with in vivo readouts, single lab","pmids":["9121454"],"is_preprint":false},{"year":1998,"finding":"The transcriptional repression domain of AREB6 (zinc finger-homeodomain transcription factor) requires NC2 (NC2alpha/DRAP1 and NC2beta/Dr1) to repress transcription. The AREB6 repression domain was inactive in a reconstituted system but restored by addition of recombinant NC2. Direct interaction between the AREB6 repression domain and NC2alpha was confirmed by yeast two-hybrid assay.","method":"In vitro transcription reconstitution, yeast two-hybrid interaction assay, transient transfection assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — reconstituted in vitro transcription plus yeast two-hybrid; single lab, two orthogonal methods","pmids":["9418848"],"is_preprint":false},{"year":2000,"finding":"Drosophila NC2 (dNC2, homolog of Dr1-DRAP1) activates transcription from DPE (downstream promoter element)-containing core promoters and represses TATA-driven promoters. A mutant version of dNC2 can activate DPE promoters but cannot repress TATA promoters, demonstrating that the activation and repression functions are genetically and biochemically distinct.","method":"Biochemical purification, in vitro transcription assays with DPE- and TATA-driven promoters, recombinant mutant NC2","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified recombinant protein, in vitro transcription assays with separation-of-function mutant; directly demonstrates bifunctionality","pmids":["11062130"],"is_preprint":false},{"year":2000,"finding":"Depletion of NC2 (Dr1/DRAP1) from HeLa nuclear extracts does not significantly affect basal transcription but dramatically reduces activated transcription. NC2 was found to co-immunoprecipitate with the CTD-hyperphosphorylated form of RNA polymerase II (RNAP IIO) but not with unphosphorylated or hypophosphorylated forms, revealing an unexpected link between NC2 and transcription activation.","method":"Immunodepletion from HeLa nuclear extracts, co-immunoprecipitation with purified factors, in vitro transcription assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — immunodepletion rescue experiments plus reciprocal co-IP, single lab, multiple orthogonal methods","pmids":["10852970"],"is_preprint":false},{"year":2000,"finding":"NC2 activity is dispensable in sin4 yeast mutants lacking a component of the SRB-MED complex. NC2 is required for transcription of HIS3 and HIS4 TATA-less core promoters (a positive role), and functions as a repressor of the HIS3 TATA promoter during diauxic shift. A sin4 mutation bypasses the essential requirement for NC2, revealing a balance between NC2 repression and holoenzyme function.","method":"Yeast genetics (mutant isolation, gene deletion, double-mutant analysis), in vivo transcription assays","journal":"Molecular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with defined readouts, single lab, multiple genetic combinations tested","pmids":["10760173"],"is_preprint":false},{"year":2001,"finding":"Crystal structure of NC2 (alpha/DRAP1 and beta/Dr1) in ternary complex with TBP and DNA determined at 2.6 Å resolution. The N termini of NC2alpha and NC2beta resemble histones H2A and H2B respectively and form a heterodimer that binds the DNA double helix on the underside of the TBP-DNA complex via electrostatic interactions. NC2beta's C-terminal alpha helix contacts TBP's upper surface, positioning a penultimate helix to block TFIIB recognition of the TBP-DNA complex.","method":"X-ray crystallography at 2.6 Å resolution","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure providing direct structural mechanism; replicated by independent functional studies","pmids":["11461703"],"is_preprint":false},{"year":2001,"finding":"Yeast NC2 (Bur6-Ydr1) associates with promoters in vivo in a manner that correlates with transcriptional activity and occupancy by basal transcription factors. NC2 rapidly associates with promoters upon transcriptional activation and remains associated when transcription is blocked after preinitiation complex assembly. NC2 positively and negatively affects ~17% of S. cerevisiae genes, and high NC2 occupancy relative to TBP correlates with promoters where NC2 is positively required.","method":"Chromatin immunoprecipitation (ChIP) at yeast promoters, genome-wide transcription profiling","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP combined with transcriptional profiling, replicated across multiple conditions","pmids":["11283253"],"is_preprint":false},{"year":2002,"finding":"DRAP1 loss in mice leads to severe gastrulation defects consistent with increased Nodal expression, which can be partially suppressed by Nodal heterozygosity (genetic epistasis). Biochemically, DRAP1 interacts with and inhibits DNA binding by the winged-helix transcription factor FoxH1 (FAST), a positive feedback regulator of Nodal signaling, thus limiting Nodal autoregulatory loop activity.","method":"Mouse knockout genetics, Nodal heterozygosity suppression epistasis, biochemical interaction/DNA-binding inhibition assays","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genetic epistasis combined with biochemical interaction assays establishing the molecular mechanism; clean in vivo phenotype with suppressor experiment","pmids":["12471260"],"is_preprint":false},{"year":2002,"finding":"Hypoxia induces NC2 (Dr1/DRAP1) protein levels, which then binds core promoters to block preinitiation complex assembly, preventing CTD phosphorylation and transcription. Immunodepletion of NC2beta/Dr1 protein complexes from hypoxic extracts rescued repressed transcription, demonstrating that NC2 is mechanistically responsible for hypoxia-induced transcriptional repression at a subset of promoters.","method":"In vitro reconstitution with hypoxic cell extracts, immunodepletion rescue experiments, preinitiation complex assembly assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in cell-free system with immunodepletion rescue; single lab but multiple orthogonal biochemical approaches","pmids":["12477712"],"is_preprint":false},{"year":2002,"finding":"The NC2alpha (Drap1/Bur6) and NC2beta (Dr1/Ydr1) subunits are not always associated in a tight complex in vivo; their association is regulated by glucose availability. Stable NC2alpha/beta complexes are only purified after the diauxic shift (glucose depletion). In vivo, NC2alpha presence at promoters correlates with TBP and transcriptional activity, whereas increased NC2beta relative to TBP correlates with repression. NC2 is regulated by casein kinase II (CKII) phosphorylation, and mutations in CKII subunits or CKII phosphorylation sites in NC2alpha and NC2beta affect gene repression.","method":"Protein complex purification under different growth conditions, chromatin immunoprecipitation, CKII phosphorylation site mutagenesis, genetic analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (biochemical purification, ChIP, phosphorylation mutagenesis), single lab","pmids":["12502746"],"is_preprint":false},{"year":2000,"finding":"Genetic analysis of YDR1-BUR6 (yeast Dr1-DRAP1) identified that the C-terminal 41 amino acids of Ydr1 are required for repressor activity. Recessive mutations in SIN4 (a SRB-MED complex component) suppress ydr1(cs) and bur6(cs) mutations and can suppress the inviability of a ydr1 deletion, establishing genetic epistasis between the Dr1-DRAP1 repressor and the SRB-MED complex.","method":"Yeast genetics (deletion mutagenesis, extragenic suppressor screen), in vitro and in vivo transcription assays, SRB-MED complex biochemical analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with biochemical validation of SRB-MED complex structure, single lab","pmids":["10713169"],"is_preprint":false},{"year":2004,"finding":"NC2alpha (DRAP1) physically interacts with BTAF1 (human ortholog of yeast Mot1p). NC2alpha (but not NC2beta) stimulates BTAF1's ATP-dependent association with TBP. NC2beta does not associate with BTAF1 and interferes with the BTAF1-TBP interaction. The stimulatory function of NC2alpha on BTAF1-TBP interaction is ATP-dependent but does not require the ATPase activity of BTAF1 or phosphorylation of NC2alpha.","method":"Co-immunoprecipitation, pull-down assays, cell-free interaction assays with ATP manipulation, mutagenesis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and pull-down with functional domain dissection, single lab, two orthogonal methods","pmids":["15509807"],"is_preprint":false},{"year":2007,"finding":"A functional initiator element (INR) in core promoters provides resistance to NC2 (Dr1/DRAP1)-mediated repression of TATA-dependent transcription. INR-mediated resistance requires TBP-associated factors (TAFs) and TAF/INR-dependent cofactor activity, and is established during transcription initiation complex assembly by strongly enhancing TFIIA and TFIIB recruitment while compromising NC2 binding.","method":"In vitro transcription assays with promoter variants, TFIIA/TFIIB recruitment assays, NC2 binding competition assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro transcription with mechanistic dissection, single lab","pmids":["17584739"],"is_preprint":false},{"year":2007,"finding":"NC2 (composed of NC2alpha/Drap1 and NC2beta/Dr1) strongly controls promoter association of TFIIB both negatively and positively in a gene-specific manner. The repressor effect on TFIIB is attributable to the C-terminal domain of NC2beta and requires ORF sequences of target genes. The positive function of NC2 on TFIIB is more general and requires adequate NC2 histone-fold heterodimer levels at promoters. Under heat stress, NC2 becomes limiting for TBP association with heat-inducible promoters.","method":"NC2 mutant generation, ChIP at target promoters, chromatin fractionation, yeast genetics","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-specific mutations with ChIP readouts in vivo, single lab, multiple gene contexts tested","pmids":["18048413"],"is_preprint":false},{"year":2008,"finding":"Site-specific protein-protein photocrosslinking demonstrated that TBP alpha-helix 2 (H2) can be crosslinked to the C-terminal tail of NC2alpha (DRAP1) in the NC2-TBP-DNA complex, a contact not visible in the crystal structure due to truncated NC2 used for crystallization. This NC2alpha C-terminal tail–TBP H2 interaction provides a structural basis for steric exclusion competition between TFIIA and NC2.","method":"Site-specific photocrosslinking with non-radioactive ultrasensitive detection, crosslink mapping","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — novel photocrosslinking method with precise mapping; single lab but rigorous biochemical method","pmids":["18824481"],"is_preprint":false},{"year":2009,"finding":"Endogenous DRAP1 (NC2alpha) is present at RNA polymerase III-transcribed genes (tRNA genes) in human cells, as detected by ChIP. DRAP1 is present at pol III templates alongside its dimerization partner Dr1 (NC2beta). However, RNAi-mediated depletion of Dr1 (not DRAP1) enhanced tRNA expression by pol III, indicating that while both subunits occupy pol III templates, DRAP1 does not influence pol III output in vivo.","method":"Chromatin immunoprecipitation in human cells, RNAi-mediated depletion, tRNA expression assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP combined with RNAi depletion functional readout; single lab, two complementary methods; negative result for DRAP1 pol III function explicitly noted","pmids":["19965767"],"is_preprint":false},{"year":2006,"finding":"FEZ1 (fasciculation and elongation protein zeta1) interacts with DRAP1 in a yeast two-hybrid screen of a human fetal brain cDNA library, and this interaction was confirmed by in vitro pull-down assays with recombinant fusion proteins. The FEZ1 C-terminal coiled-coil region mediates this interaction.","method":"Yeast two-hybrid assay, in vitro pull-down with recombinant proteins","journal":"The Journal of biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single yeast two-hybrid plus pull-down confirmation; no functional consequence of the DRAP1-FEZ1 interaction established","pmids":["16484223"],"is_preprint":false},{"year":2024,"finding":"The DR1/DRAP1 heterodimer complex in triple-negative breast cancer (TNBC) represses transcription of CASTOR1 (cytosolic arginine sensor for mTORC1 subunit 1), thereby increasing mTOR activation and promoting TNBC proliferation, migration, invasion, and metastasis. DRAP1 also enhances DR1 protein stability by recruiting deubiquitinase USP7 to inhibit its proteasomal degradation, and in turn DR1 directly promotes DRAP1 transcription, forming a positive feedback loop.","method":"In vitro loss-of-function (KD/KO) with proliferation, migration, invasion assays; in vivo tumor growth/metastasis models; mechanistic assays for CASTOR1 repression and mTOR activation; co-immunoprecipitation for USP7 recruitment; proteasomal degradation assays; promoter transcription assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (KD, co-IP, functional assays, in vivo models), single lab","pmids":["38748783"],"is_preprint":false}],"current_model":"DRAP1 (NC2alpha) forms a histone fold-containing heterodimer with DR1 (NC2beta) that binds TBP-DNA complexes and globally represses RNA Pol II transcription by blocking TFIIA/TFIIB entry into the preinitiation complex; it also activates DPE-dependent transcription in opposition to TATA repression; in vivo it inhibits the FoxH1-mediated Nodal autoregulatory loop during gastrulation, is regulated by casein kinase II phosphorylation and by association with BTAF1, and in cancer contexts recruits USP7 to stabilize DR1 while the DR1/DRAP1 complex represses CASTOR1 to activate mTOR signaling."},"narrative":{"mechanistic_narrative":"DRAP1 (NC2alpha) is a histone-fold transcriptional regulator that, together with DR1 (NC2beta), forms the negative cofactor 2 (NC2) heterodimer governing RNA polymerase II preinitiation [PMID:8608938, PMID:11461703]. The N-terminal histone-fold domains of the two subunits resemble histones H2A and H2B and dimerize to clamp the underside of the TBP-DNA complex, stabilizing TBP on the TATA box while blocking entry of TFIIA and TFIIB into the preinitiation complex [PMID:8608938, PMID:11461703, PMID:18824481]. NC2 acts as a global, TBP-targeted repressor of class II (and class III) transcription in vivo, an activity conserved from yeast (Bur6/Ydr1) to human and genetically antagonistic to the SRB-MED (Mediator) holoenzyme [PMID:9023340, PMID:9096360, PMID:10713169]. NC2 is bifunctional rather than purely repressive: it activates transcription from DPE-containing core promoters while repressing TATA-driven promoters, with these activities separable by mutation [PMID:11062130], and it is required positively for a substantial fraction of genes, associating with active promoters in correlation with TBP occupancy [PMID:11283253, PMID:12502746]. Its repressive output is gated by signals and partners — induced by hypoxia to shut down preinitiation [PMID:12477712], modulated by casein kinase II phosphorylation and glucose-dependent subunit association [PMID:12502746], and tuned by interaction with BTAF1/Mot1, where NC2alpha specifically stimulates ATP-dependent BTAF1-TBP association [PMID:15509807]. Beyond core transcription, DRAP1 restrains developmental signaling by binding and inhibiting DNA binding of the FoxH1 (FAST) transcription factor, thereby limiting the Nodal autoregulatory loop; its loss in mice causes severe gastrulation defects suppressible by Nodal heterozygosity [PMID:12471260]. In triple-negative breast cancer, the DR1/DRAP1 complex represses CASTOR1 to activate mTOR signaling and drive tumor progression, with DRAP1 recruiting the deubiquitinase USP7 to stabilize DR1 [PMID:38748783].","teleology":[{"year":1996,"claim":"Established that DRAP1 is a corepressor that physically partners DR1 through a histone fold and acts on the basal transcription machinery, defining the molecular basis of repression.","evidence":"Biochemical purification from HeLa cells, in vitro transcription, and histone fold domain mutagenesis","pmids":["8608938"],"confidence":"High","gaps":["Did not resolve the atomic geometry of TBP contact","Did not address positive/activating roles"]},{"year":1997,"claim":"Demonstrated that the DR1/DRAP1 (NC2) complex is a global, essential repressor acting by directly targeting TBP in vivo, and dissected which DR1 domains tether TBP versus repress.","evidence":"Yeast genetics (essential gene deletion, overexpression/TBP rescue) and reconstituted Pol II transcription with domain deletions","pmids":["9023340","8972183"],"confidence":"High","gaps":["Did not define DRAP1's own contribution to TBP contact independent of DR1","Did not explain promoter-specific effects"]},{"year":1997,"claim":"Placed NC2 in functional opposition to the Pol II holoenzyme by showing NC2 defects suppress SRB4 mutations, establishing it as a global negative regulator antagonizing Mediator.","evidence":"Genetic suppressor screen and in vivo mRNA synthesis measurement in yeast; systematic Bur6 histone-fold deletion analysis","pmids":["9096360","9121454"],"confidence":"Medium","gaps":["Mechanism of holoenzyme antagonism not biochemically reconstituted","Promoter-context dependence not yet explained"]},{"year":1998,"claim":"Showed NC2/DRAP1 is recruited as a corepressor by sequence-specific factors, linking the basal repressor to gene-specific regulation via direct AREB6 contact.","evidence":"In vitro transcription reconstitution and yeast two-hybrid with the AREB6 repression domain","pmids":["9418848"],"confidence":"Medium","gaps":["Single corepressor relationship; generality across other factors untested","In vivo relevance not established"]},{"year":2000,"claim":"Revealed NC2 as bifunctional — activating DPE promoters while repressing TATA promoters — and that these are separable activities, overturning a purely repressive model.","evidence":"Purified recombinant Drosophila NC2 with DPE/TATA in vitro transcription and a separation-of-function mutant","pmids":["11062130"],"confidence":"High","gaps":["Structural basis of DPE activation not defined","Did not map DRAP1-specific residues for activation"]},{"year":2000,"claim":"Connected NC2 to activated transcription and to the elongating polymerase, showing it is dispensable for basal but required for activated transcription and associates with hyperphosphorylated Pol IIO.","evidence":"Immunodepletion/rescue from HeLa extracts and co-IP with Pol II isoforms; complementary yeast sin4-bypass genetics","pmids":["10852970","10760173"],"confidence":"High","gaps":["Direct vs indirect association with Pol IIO not resolved","Did not identify the activated promoter determinants"]},{"year":2000,"claim":"Localized DR1 repressor activity to its C-terminus and cemented genetic epistasis between the DR1-DRAP1 repressor and the SRB-MED complex.","evidence":"Yeast deletion mutagenesis, extragenic SIN4 suppressor screen, and SRB-MED biochemical analysis","pmids":["10713169"],"confidence":"Medium","gaps":["Physical interface with Mediator not defined","DRAP1-specific contribution not separated"]},{"year":2001,"claim":"Provided the atomic mechanism: the NC2alpha/NC2beta histone-fold heterodimer grips DNA under TBP and positions a helix to sterically block TFIIB.","evidence":"X-ray crystallography of the NC2-TBP-DNA ternary complex at 2.6 Å","pmids":["11461703"],"confidence":"High","gaps":["Truncated NC2 omitted the C-terminal tails, missing the TFIIA-exclusion contact","Static structure did not capture DPE-activation conformation"]},{"year":2001,"claim":"Showed in vivo that NC2 occupancy tracks transcriptional activity genome-wide and can be positive or negative, reframing it as a context-dependent regulator of ~17% of genes.","evidence":"ChIP at yeast promoters with genome-wide transcription profiling","pmids":["11283253"],"confidence":"High","gaps":["What determines positive vs negative outcome at a given promoter unresolved","DRAP1 vs DR1 individual occupancy not separated"]},{"year":2002,"claim":"Identified an in vivo physiological role distinct from core transcription: DRAP1 binds and inhibits FoxH1 DNA binding to limit Nodal signaling during gastrulation.","evidence":"Mouse knockout with Nodal-heterozygosity suppression and biochemical FoxH1 DNA-binding inhibition assays","pmids":["12471260"],"confidence":"High","gaps":["Whether DR1 is required for FoxH1 inhibition not established","Direct structural basis of FoxH1 contact unknown"]},{"year":2002,"claim":"Defined a signal-responsive repression mechanism: hypoxia raises NC2 levels to block preinitiation complex assembly and CTD phosphorylation at target promoters.","evidence":"Hypoxic extract reconstitution with immunodepletion rescue and PIC assembly assays","pmids":["12477712"],"confidence":"High","gaps":["Pathway linking hypoxia to NC2 induction not defined","Target promoter selectivity not mapped"]},{"year":2002,"claim":"Showed NC2 is a dynamically regulated complex — subunit association is glucose-dependent and CKII phosphorylation tunes repression — and that NC2alpha vs NC2beta occupancy predicts opposite outcomes.","evidence":"Conditional complex purification, ChIP, and CKII phosphosite mutagenesis in yeast","pmids":["12502746"],"confidence":"High","gaps":["Functional consequence of free NC2alpha not fully defined","CKII targets in mammalian DRAP1 not validated"]},{"year":2004,"claim":"Distinguished the two subunits functionally at the level of TBP-handling enzymes: NC2alpha (DRAP1) uniquely stimulates BTAF1/Mot1 ATP-dependent TBP association, whereas NC2beta antagonizes it.","evidence":"Reciprocal co-IP/pull-down with ATP manipulation and mutagenesis","pmids":["15509807"],"confidence":"Medium","gaps":["In vivo significance of DRAP1-BTAF1 stimulation untested","How this integrates with repression not resolved"]},{"year":2007,"claim":"Refined NC2's gene-specific regulation of TFIIB recruitment and identified promoter elements (INR, ORF sequences) that dictate resistance or sensitivity to repression.","evidence":"In vitro transcription with promoter variants and TFIIA/TFIIB recruitment assays; NC2 mutant ChIP across genes","pmids":["17584739","18048413"],"confidence":"Medium","gaps":["How ORF sequences feed back to promoter NC2 effect mechanistically unclear","DRAP1-specific role in TFIIB control not isolated"]},{"year":2008,"claim":"Filled a structural gap by mapping a crystallographically invisible NC2alpha C-terminal tail–TBP helix-2 contact that explains TFIIA exclusion.","evidence":"Site-specific protein-protein photocrosslinking with crosslink mapping","pmids":["18824481"],"confidence":"Medium","gaps":["Contact inferred from crosslinking, not high-resolution structure","Functional necessity of this tail contact not separately tested"]},{"year":2009,"claim":"Showed DRAP1 occupies Pol III (tRNA) templates but, unlike DR1, does not influence Pol III output, dissociating DRAP1 occupancy from function at these genes.","evidence":"ChIP and RNAi depletion with tRNA expression readout in human cells","pmids":["19965767"],"confidence":"Medium","gaps":["Why DRAP1 is present without functional effect unexplained","Reciprocal DR1-independent DRAP1 roles untested"]},{"year":2024,"claim":"Extended DRAP1 to disease mechanism: in TNBC the DR1/DRAP1 complex represses CASTOR1 to activate mTOR, with DRAP1 recruiting USP7 to stabilize DR1 in a feedback loop.","evidence":"Loss-of-function functional assays, in vivo tumor models, co-IP for USP7, and CASTOR1/mTOR mechanistic assays","pmids":["38748783"],"confidence":"Medium","gaps":["Whether CASTOR1 repression uses the canonical NC2-TBP mechanism not shown","USP7 recruitment interface not mapped","Single-lab single-cancer-context findings"]},{"year":null,"claim":"How DRAP1 occupancy is translated into either activation or repression at a specific promoter, and the structural and signaling determinants that switch its bifunctional output, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking DPE activation to TATA repression at residue level","Mammalian regulatory inputs (phosphorylation, partner switching) incompletely defined","Generality of cancer-context CASTOR1/mTOR axis beyond TNBC unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,6,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,9,15]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,9]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[9]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,11]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,10,11]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[10,19]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,9,10]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[21]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,21]}],"complexes":["NC2 (DR1-DRAP1) heterodimer"],"partners":["DR1","TBP","BTAF1","FOXH1","USP7","AREB6","FEZ1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q14919","full_name":"Dr1-associated corepressor","aliases":["Dr1-associated protein 1","Negative cofactor 2-alpha","NC2-alpha"],"length_aa":205,"mass_kda":22.4,"function":"The association of the DR1/DRAP1 heterodimer with TBP results in a functional repression of both activated and basal transcription of class II genes. This interaction precludes the formation of a transcription-competent complex by inhibiting the association of TFIIA and/or TFIIB with TBP. Can bind to DNA on its own","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q14919/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DRAP1","classification":"Not Classified","n_dependent_lines":527,"n_total_lines":1208,"dependency_fraction":0.43625827814569534},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"TBP","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DRAP1","total_profiled":1310},"omim":[{"mim_id":"603621","title":"FORKHEAD BOX H1; FOXH1","url":"https://www.omim.org/entry/603621"},{"mim_id":"602289","title":"DR1-ASSOCIATED PROTEIN 1; DRAP1","url":"https://www.omim.org/entry/602289"},{"mim_id":"601482","title":"DOWNREGULATOR OF TRANSCRIPTION 1, TBP-BINDING; DR1","url":"https://www.omim.org/entry/601482"},{"mim_id":"601265","title":"NODAL GROWTH DIFFERENTIATION FACTOR; NODAL","url":"https://www.omim.org/entry/601265"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DRAP1"},"hgnc":{"alias_symbol":["NC2-alpha"],"prev_symbol":[]},"alphafold":{"accession":"Q14919","domains":[{"cath_id":"1.10.20.10","chopping":"13-85","consensus_level":"medium","plddt":96.5688,"start":13,"end":85}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14919","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14919-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14919-F1-predicted_aligned_error_v6.png","plddt_mean":73.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DRAP1","jax_strain_url":"https://www.jax.org/strain/search?query=DRAP1"},"sequence":{"accession":"Q14919","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14919.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14919/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14919"}},"corpus_meta":[{"pmid":"14570583","id":"PMC_14570583","title":"Nodal signaling in vertebrate development.","date":"2003","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14570583","citation_count":501,"is_preprint":false},{"pmid":"11062130","id":"PMC_11062130","title":"A basal transcription factor that activates or represses transcription.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11062130","citation_count":134,"is_preprint":false},{"pmid":"11461703","id":"PMC_11461703","title":"Crystal structure of negative cofactor 2 recognizing the TBP-DNA transcription complex.","date":"2001","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11461703","citation_count":124,"is_preprint":false},{"pmid":"8608938","id":"PMC_8608938","title":"Requirement of a corepressor for Dr1-mediated repression of transcription.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8608938","citation_count":115,"is_preprint":false},{"pmid":"27135365","id":"PMC_27135365","title":"Cross-Tissue Regulatory Gene Networks in Coronary Artery Disease.","date":"2016","source":"Cell systems","url":"https://pubmed.ncbi.nlm.nih.gov/27135365","citation_count":115,"is_preprint":false},{"pmid":"9023340","id":"PMC_9023340","title":"The Dr1/DRAP1 heterodimer is a global repressor of transcription in vivo.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9023340","citation_count":86,"is_preprint":false},{"pmid":"9121454","id":"PMC_9121454","title":"Saccharomyces cerevisiae BUR6 encodes a DRAP1/NC2alpha homolog that has both positive and negative roles in transcription in vivo.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9121454","citation_count":83,"is_preprint":false},{"pmid":"12515390","id":"PMC_12515390","title":"The DPE, a core promoter element for transcription by RNA polymerase II.","date":"2002","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12515390","citation_count":82,"is_preprint":false},{"pmid":"12471260","id":"PMC_12471260","title":"Inhibition of excess nodal signaling during mouse gastrulation by the transcriptional corepressor DRAP1.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12471260","citation_count":70,"is_preprint":false},{"pmid":"11283253","id":"PMC_11283253","title":"Yeast NC2 associates with the RNA polymerase II preinitiation complex and selectively affects transcription in vivo.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11283253","citation_count":63,"is_preprint":false},{"pmid":"9096360","id":"PMC_9096360","title":"Functional antagonism between RNA polymerase II holoenzyme and global negative regulator NC2 in vivo.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9096360","citation_count":55,"is_preprint":false},{"pmid":"32182071","id":"PMC_32182071","title":"Accelerated Lysis and Proteolytic Digestion of Biopsy-Level Fresh-Frozen and FFPE Tissue Samples Using Pressure Cycling Technology.","date":"2020","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/32182071","citation_count":50,"is_preprint":false},{"pmid":"9418848","id":"PMC_9418848","title":"Involvement of negative cofactor NC2 in active repression by zinc finger-homeodomain transcription factor AREB6.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9418848","citation_count":47,"is_preprint":false},{"pmid":"19211196","id":"PMC_19211196","title":"To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.","date":"2009","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/19211196","citation_count":42,"is_preprint":false},{"pmid":"12477712","id":"PMC_12477712","title":"Hypoxia actively represses transcription by inducing negative cofactor 2 (Dr1/DrAP1) and blocking preinitiation complex assembly.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12477712","citation_count":39,"is_preprint":false},{"pmid":"16484223","id":"PMC_16484223","title":"FEZ1 dimerization and interaction with transcription regulatory proteins involves its coiled-coil region.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16484223","citation_count":39,"is_preprint":false},{"pmid":"10760173","id":"PMC_10760173","title":"The NC2 repressor is dispensable in yeast mutated for the Sin4p component of the holoenzyme and plays roles similar to Mot1p in vivo.","date":"2000","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10760173","citation_count":38,"is_preprint":false},{"pmid":"15723799","id":"PMC_15723799","title":"Ras-independent activation of ERK signaling via the torso receptor tyrosine kinase is mediated by Rap1.","date":"2005","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15723799","citation_count":34,"is_preprint":false},{"pmid":"8972183","id":"PMC_8972183","title":"Functional dissection of a human Dr1-DRAP1 repressor complex.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8972183","citation_count":33,"is_preprint":false},{"pmid":"10852970","id":"PMC_10852970","title":"The C-terminal domain-phosphorylated IIO form of RNA polymerase II is associated with the transcription repressor NC2 (Dr1/DRAP1) and is required for transcription activation in human nuclear extracts.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10852970","citation_count":32,"is_preprint":false},{"pmid":"31893575","id":"PMC_31893575","title":"FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31893575","citation_count":32,"is_preprint":false},{"pmid":"9399877","id":"PMC_9399877","title":"Histone Sequence Database: new histone fold family members.","date":"1998","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9399877","citation_count":31,"is_preprint":false},{"pmid":"12502746","id":"PMC_12502746","title":"The NC2 alpha and beta subunits play different roles in vivo.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12502746","citation_count":25,"is_preprint":false},{"pmid":"15509807","id":"PMC_15509807","title":"NC2alpha interacts with BTAF1 and stimulates its ATP-dependent association with TATA-binding protein.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15509807","citation_count":25,"is_preprint":false},{"pmid":"17584739","id":"PMC_17584739","title":"The initiator core promoter element antagonizes repression of TATA-directed transcription by negative cofactor NC2.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17584739","citation_count":22,"is_preprint":false},{"pmid":"25865298","id":"PMC_25865298","title":"Evaluation of housekeeping genes for normalizing real-time quantitative PCR assays in pig skeletal muscle at multiple developmental stages.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25865298","citation_count":21,"is_preprint":false},{"pmid":"10713169","id":"PMC_10713169","title":"Genetic analysis of the YDR1-BUR6 repressor complex reveals an intricate balance among transcriptional regulatory proteins in yeast.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10713169","citation_count":20,"is_preprint":false},{"pmid":"18048413","id":"PMC_18048413","title":"The dual control of TFIIB recruitment by NC2 is gene specific.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18048413","citation_count":18,"is_preprint":false},{"pmid":"36672132","id":"PMC_36672132","title":"The Role of Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis: Identification of Signaling Pathways, Regulators, Molecular Interaction Networks, and Biological Functions through Bioinformatics.","date":"2023","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36672132","citation_count":14,"is_preprint":false},{"pmid":"11826307","id":"PMC_11826307","title":"Functional dissection of a Rice Dr1/DrAp1 transcriptional repression complex.","date":"2002","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/11826307","citation_count":13,"is_preprint":false},{"pmid":"34588774","id":"PMC_34588774","title":"Transcriptomics Analysis Identifies the Presence of Upregulated Ribosomal Housekeeping Genes in the Alveolar Macrophages of Patients with Smoking-Induced Chronic Obstructive Pulmonary Disease.","date":"2021","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/34588774","citation_count":13,"is_preprint":false},{"pmid":"33167455","id":"PMC_33167455","title":"TaDrAp1 and TaDrAp2, Partner Genes of a Transcription Repressor, Coordinate Plant Development and Drought Tolerance in Spelt and Bread Wheat.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33167455","citation_count":10,"is_preprint":false},{"pmid":"33846365","id":"PMC_33846365","title":"A flexible microfluidic system for single-cell transcriptome profiling elucidates phased transcriptional regulators of cell cycle.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33846365","citation_count":9,"is_preprint":false},{"pmid":"38748783","id":"PMC_38748783","title":"The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38748783","citation_count":7,"is_preprint":false},{"pmid":"19965767","id":"PMC_19965767","title":"Dr1 (NC2) is present at tRNA genes and represses their transcription in human cells.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19965767","citation_count":7,"is_preprint":false},{"pmid":"18824481","id":"PMC_18824481","title":"Nonradioactive, ultrasensitive site-specific protein-protein photocrosslinking: interactions of alpha-helix 2 of TATA-binding protein with general transcription factor TFIIA and transcriptional repressor NC2.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18824481","citation_count":6,"is_preprint":false},{"pmid":"34493366","id":"PMC_34493366","title":"Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/34493366","citation_count":5,"is_preprint":false},{"pmid":"27273137","id":"PMC_27273137","title":"Analysis of extraembryonic mesodermal structure formation in the absence of morphological primitive streak.","date":"2016","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/27273137","citation_count":4,"is_preprint":false},{"pmid":"33888032","id":"PMC_33888032","title":"Shared ancestry of core-histone subunits and non-histone plant proteins containing the Histone Fold Motif (HFM).","date":"2021","source":"Journal of bioinformatics and computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/33888032","citation_count":3,"is_preprint":false},{"pmid":"32550556","id":"PMC_32550556","title":"Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.","date":"2020","source":"Gene: X","url":"https://pubmed.ncbi.nlm.nih.gov/32550556","citation_count":3,"is_preprint":false},{"pmid":"16511166","id":"PMC_16511166","title":"The structure at 2.5 A resolution of human basophilic leukemia-expressed protein BLES03.","date":"2005","source":"Acta crystallographica. Section F, Structural biology and crystallization communications","url":"https://pubmed.ncbi.nlm.nih.gov/16511166","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20599,"output_tokens":5873,"usd":0.074946,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14520,"output_tokens":5162,"usd":0.100825,"stage2_stop_reason":"end_turn"},"total_usd":0.175771,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"DRAP1 was isolated from HeLa cells as a Dr1-associated polypeptide that functions as a transcriptional corepressor. Corepressor function requires direct interaction between DRAP1 and Dr1 via a histone fold motif present at the amino terminus of both polypeptides. Association of DRAP1 with Dr1 increases stability of the Dr1-TBP-TATA motif complex and precludes entry of TFIIA and/or TFIIB into preinitiation complexes.\",\n      \"method\": \"Biochemical purification from HeLa cells, in vitro transcription assays, protein interaction studies, histone fold domain mutagenesis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original biochemical reconstitution with in vitro transcription assays, domain mutagenesis, and isolation from native cells; foundational paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"8608938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The Dr1/DRAP1 heterodimer functions as a global repressor of RNA polymerase II transcription in vivo. Yeast orthologs YDR1 (Dr1) and BUR6 (DRAP1) are encoded by essential genes; the complex represses transcription by directly targeting TBP. Overexpression of Dr1 in vivo reduces mRNA accumulation and impairs cell growth, both effects reversible by TBP overexpression. The complex also represses RNA polymerase III but not RNA polymerase I transcripts.\",\n      \"method\": \"Yeast genetics (gene deletion, overexpression, rescue experiments), in vitro reconstituted Pol II transcription system, mRNA accumulation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and biochemical approaches in yeast, replicated in vitro; consistent with independent biochemical findings from multiple labs\",\n      \"pmids\": [\"9023340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Functional dissection of the Dr1-DRAP1 complex showed that Dr1 contains a TBP-tethering domain and a separate glutamine-alanine-rich repression domain. DRAP1 enhancement of Dr1-mediated repression requires the Dr1 tethering domain; DRAP1 interaction with Dr1 lacking the tethering domain is not functional for repression. The repression domain of Dr1 directly and functionally interacts with TBP.\",\n      \"method\": \"Domain deletion mutagenesis, in vitro transcription assays, protein-protein interaction assays with recombinant proteins\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with domain mutagenesis, single lab but multiple orthogonal functional assays\",\n      \"pmids\": [\"8972183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"A defect in the yeast NC2 (Dr1×DRAP1) suppresses mutations in SRB4 (an RNA polymerase II holoenzyme component), establishing NC2 as a global negative regulator of class II transcription in vivo that functionally antagonizes the Pol II holoenzyme.\",\n      \"method\": \"Genetic suppressor screen, in vivo mRNA synthesis measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in yeast, single lab, two complementary genetic approaches\",\n      \"pmids\": [\"9096360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The yeast BUR6 gene encodes a DRAP1/NC2alpha homolog. The histone fold domain of Bur6p is required for function in vivo; extensive deletion alleles throughout the histone fold domain impair function, whereas mutations in amino- and carboxy-terminal tails have no effect. BUR6 and BUR3/MOT1 have different functions depending on promoter context: both increase transcription from TATA-less UAS-deleted promoters but reduce transcription from the wild-type GAL1 and GAL10 promoters.\",\n      \"method\": \"Molecular cloning, deletion mutagenesis, in vivo transcription assays in yeast\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic domain mutagenesis with in vivo readouts, single lab\",\n      \"pmids\": [\"9121454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The transcriptional repression domain of AREB6 (zinc finger-homeodomain transcription factor) requires NC2 (NC2alpha/DRAP1 and NC2beta/Dr1) to repress transcription. The AREB6 repression domain was inactive in a reconstituted system but restored by addition of recombinant NC2. Direct interaction between the AREB6 repression domain and NC2alpha was confirmed by yeast two-hybrid assay.\",\n      \"method\": \"In vitro transcription reconstitution, yeast two-hybrid interaction assay, transient transfection assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — reconstituted in vitro transcription plus yeast two-hybrid; single lab, two orthogonal methods\",\n      \"pmids\": [\"9418848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Drosophila NC2 (dNC2, homolog of Dr1-DRAP1) activates transcription from DPE (downstream promoter element)-containing core promoters and represses TATA-driven promoters. A mutant version of dNC2 can activate DPE promoters but cannot repress TATA promoters, demonstrating that the activation and repression functions are genetically and biochemically distinct.\",\n      \"method\": \"Biochemical purification, in vitro transcription assays with DPE- and TATA-driven promoters, recombinant mutant NC2\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified recombinant protein, in vitro transcription assays with separation-of-function mutant; directly demonstrates bifunctionality\",\n      \"pmids\": [\"11062130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Depletion of NC2 (Dr1/DRAP1) from HeLa nuclear extracts does not significantly affect basal transcription but dramatically reduces activated transcription. NC2 was found to co-immunoprecipitate with the CTD-hyperphosphorylated form of RNA polymerase II (RNAP IIO) but not with unphosphorylated or hypophosphorylated forms, revealing an unexpected link between NC2 and transcription activation.\",\n      \"method\": \"Immunodepletion from HeLa nuclear extracts, co-immunoprecipitation with purified factors, in vitro transcription assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — immunodepletion rescue experiments plus reciprocal co-IP, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"10852970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NC2 activity is dispensable in sin4 yeast mutants lacking a component of the SRB-MED complex. NC2 is required for transcription of HIS3 and HIS4 TATA-less core promoters (a positive role), and functions as a repressor of the HIS3 TATA promoter during diauxic shift. A sin4 mutation bypasses the essential requirement for NC2, revealing a balance between NC2 repression and holoenzyme function.\",\n      \"method\": \"Yeast genetics (mutant isolation, gene deletion, double-mutant analysis), in vivo transcription assays\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with defined readouts, single lab, multiple genetic combinations tested\",\n      \"pmids\": [\"10760173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Crystal structure of NC2 (alpha/DRAP1 and beta/Dr1) in ternary complex with TBP and DNA determined at 2.6 Å resolution. The N termini of NC2alpha and NC2beta resemble histones H2A and H2B respectively and form a heterodimer that binds the DNA double helix on the underside of the TBP-DNA complex via electrostatic interactions. NC2beta's C-terminal alpha helix contacts TBP's upper surface, positioning a penultimate helix to block TFIIB recognition of the TBP-DNA complex.\",\n      \"method\": \"X-ray crystallography at 2.6 Å resolution\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure providing direct structural mechanism; replicated by independent functional studies\",\n      \"pmids\": [\"11461703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Yeast NC2 (Bur6-Ydr1) associates with promoters in vivo in a manner that correlates with transcriptional activity and occupancy by basal transcription factors. NC2 rapidly associates with promoters upon transcriptional activation and remains associated when transcription is blocked after preinitiation complex assembly. NC2 positively and negatively affects ~17% of S. cerevisiae genes, and high NC2 occupancy relative to TBP correlates with promoters where NC2 is positively required.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) at yeast promoters, genome-wide transcription profiling\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP combined with transcriptional profiling, replicated across multiple conditions\",\n      \"pmids\": [\"11283253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DRAP1 loss in mice leads to severe gastrulation defects consistent with increased Nodal expression, which can be partially suppressed by Nodal heterozygosity (genetic epistasis). Biochemically, DRAP1 interacts with and inhibits DNA binding by the winged-helix transcription factor FoxH1 (FAST), a positive feedback regulator of Nodal signaling, thus limiting Nodal autoregulatory loop activity.\",\n      \"method\": \"Mouse knockout genetics, Nodal heterozygosity suppression epistasis, biochemical interaction/DNA-binding inhibition assays\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genetic epistasis combined with biochemical interaction assays establishing the molecular mechanism; clean in vivo phenotype with suppressor experiment\",\n      \"pmids\": [\"12471260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hypoxia induces NC2 (Dr1/DRAP1) protein levels, which then binds core promoters to block preinitiation complex assembly, preventing CTD phosphorylation and transcription. Immunodepletion of NC2beta/Dr1 protein complexes from hypoxic extracts rescued repressed transcription, demonstrating that NC2 is mechanistically responsible for hypoxia-induced transcriptional repression at a subset of promoters.\",\n      \"method\": \"In vitro reconstitution with hypoxic cell extracts, immunodepletion rescue experiments, preinitiation complex assembly assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in cell-free system with immunodepletion rescue; single lab but multiple orthogonal biochemical approaches\",\n      \"pmids\": [\"12477712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The NC2alpha (Drap1/Bur6) and NC2beta (Dr1/Ydr1) subunits are not always associated in a tight complex in vivo; their association is regulated by glucose availability. Stable NC2alpha/beta complexes are only purified after the diauxic shift (glucose depletion). In vivo, NC2alpha presence at promoters correlates with TBP and transcriptional activity, whereas increased NC2beta relative to TBP correlates with repression. NC2 is regulated by casein kinase II (CKII) phosphorylation, and mutations in CKII subunits or CKII phosphorylation sites in NC2alpha and NC2beta affect gene repression.\",\n      \"method\": \"Protein complex purification under different growth conditions, chromatin immunoprecipitation, CKII phosphorylation site mutagenesis, genetic analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (biochemical purification, ChIP, phosphorylation mutagenesis), single lab\",\n      \"pmids\": [\"12502746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Genetic analysis of YDR1-BUR6 (yeast Dr1-DRAP1) identified that the C-terminal 41 amino acids of Ydr1 are required for repressor activity. Recessive mutations in SIN4 (a SRB-MED complex component) suppress ydr1(cs) and bur6(cs) mutations and can suppress the inviability of a ydr1 deletion, establishing genetic epistasis between the Dr1-DRAP1 repressor and the SRB-MED complex.\",\n      \"method\": \"Yeast genetics (deletion mutagenesis, extragenic suppressor screen), in vitro and in vivo transcription assays, SRB-MED complex biochemical analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with biochemical validation of SRB-MED complex structure, single lab\",\n      \"pmids\": [\"10713169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NC2alpha (DRAP1) physically interacts with BTAF1 (human ortholog of yeast Mot1p). NC2alpha (but not NC2beta) stimulates BTAF1's ATP-dependent association with TBP. NC2beta does not associate with BTAF1 and interferes with the BTAF1-TBP interaction. The stimulatory function of NC2alpha on BTAF1-TBP interaction is ATP-dependent but does not require the ATPase activity of BTAF1 or phosphorylation of NC2alpha.\",\n      \"method\": \"Co-immunoprecipitation, pull-down assays, cell-free interaction assays with ATP manipulation, mutagenesis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and pull-down with functional domain dissection, single lab, two orthogonal methods\",\n      \"pmids\": [\"15509807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A functional initiator element (INR) in core promoters provides resistance to NC2 (Dr1/DRAP1)-mediated repression of TATA-dependent transcription. INR-mediated resistance requires TBP-associated factors (TAFs) and TAF/INR-dependent cofactor activity, and is established during transcription initiation complex assembly by strongly enhancing TFIIA and TFIIB recruitment while compromising NC2 binding.\",\n      \"method\": \"In vitro transcription assays with promoter variants, TFIIA/TFIIB recruitment assays, NC2 binding competition assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro transcription with mechanistic dissection, single lab\",\n      \"pmids\": [\"17584739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NC2 (composed of NC2alpha/Drap1 and NC2beta/Dr1) strongly controls promoter association of TFIIB both negatively and positively in a gene-specific manner. The repressor effect on TFIIB is attributable to the C-terminal domain of NC2beta and requires ORF sequences of target genes. The positive function of NC2 on TFIIB is more general and requires adequate NC2 histone-fold heterodimer levels at promoters. Under heat stress, NC2 becomes limiting for TBP association with heat-inducible promoters.\",\n      \"method\": \"NC2 mutant generation, ChIP at target promoters, chromatin fractionation, yeast genetics\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific mutations with ChIP readouts in vivo, single lab, multiple gene contexts tested\",\n      \"pmids\": [\"18048413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Site-specific protein-protein photocrosslinking demonstrated that TBP alpha-helix 2 (H2) can be crosslinked to the C-terminal tail of NC2alpha (DRAP1) in the NC2-TBP-DNA complex, a contact not visible in the crystal structure due to truncated NC2 used for crystallization. This NC2alpha C-terminal tail–TBP H2 interaction provides a structural basis for steric exclusion competition between TFIIA and NC2.\",\n      \"method\": \"Site-specific photocrosslinking with non-radioactive ultrasensitive detection, crosslink mapping\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — novel photocrosslinking method with precise mapping; single lab but rigorous biochemical method\",\n      \"pmids\": [\"18824481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Endogenous DRAP1 (NC2alpha) is present at RNA polymerase III-transcribed genes (tRNA genes) in human cells, as detected by ChIP. DRAP1 is present at pol III templates alongside its dimerization partner Dr1 (NC2beta). However, RNAi-mediated depletion of Dr1 (not DRAP1) enhanced tRNA expression by pol III, indicating that while both subunits occupy pol III templates, DRAP1 does not influence pol III output in vivo.\",\n      \"method\": \"Chromatin immunoprecipitation in human cells, RNAi-mediated depletion, tRNA expression assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP combined with RNAi depletion functional readout; single lab, two complementary methods; negative result for DRAP1 pol III function explicitly noted\",\n      \"pmids\": [\"19965767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FEZ1 (fasciculation and elongation protein zeta1) interacts with DRAP1 in a yeast two-hybrid screen of a human fetal brain cDNA library, and this interaction was confirmed by in vitro pull-down assays with recombinant fusion proteins. The FEZ1 C-terminal coiled-coil region mediates this interaction.\",\n      \"method\": \"Yeast two-hybrid assay, in vitro pull-down with recombinant proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single yeast two-hybrid plus pull-down confirmation; no functional consequence of the DRAP1-FEZ1 interaction established\",\n      \"pmids\": [\"16484223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The DR1/DRAP1 heterodimer complex in triple-negative breast cancer (TNBC) represses transcription of CASTOR1 (cytosolic arginine sensor for mTORC1 subunit 1), thereby increasing mTOR activation and promoting TNBC proliferation, migration, invasion, and metastasis. DRAP1 also enhances DR1 protein stability by recruiting deubiquitinase USP7 to inhibit its proteasomal degradation, and in turn DR1 directly promotes DRAP1 transcription, forming a positive feedback loop.\",\n      \"method\": \"In vitro loss-of-function (KD/KO) with proliferation, migration, invasion assays; in vivo tumor growth/metastasis models; mechanistic assays for CASTOR1 repression and mTOR activation; co-immunoprecipitation for USP7 recruitment; proteasomal degradation assays; promoter transcription assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (KD, co-IP, functional assays, in vivo models), single lab\",\n      \"pmids\": [\"38748783\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DRAP1 (NC2alpha) forms a histone fold-containing heterodimer with DR1 (NC2beta) that binds TBP-DNA complexes and globally represses RNA Pol II transcription by blocking TFIIA/TFIIB entry into the preinitiation complex; it also activates DPE-dependent transcription in opposition to TATA repression; in vivo it inhibits the FoxH1-mediated Nodal autoregulatory loop during gastrulation, is regulated by casein kinase II phosphorylation and by association with BTAF1, and in cancer contexts recruits USP7 to stabilize DR1 while the DR1/DRAP1 complex represses CASTOR1 to activate mTOR signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DRAP1 (NC2alpha) is a histone-fold transcriptional regulator that, together with DR1 (NC2beta), forms the negative cofactor 2 (NC2) heterodimer governing RNA polymerase II preinitiation [#0, #9]. The N-terminal histone-fold domains of the two subunits resemble histones H2A and H2B and dimerize to clamp the underside of the TBP-DNA complex, stabilizing TBP on the TATA box while blocking entry of TFIIA and TFIIB into the preinitiation complex [#0, #9, #18]. NC2 acts as a global, TBP-targeted repressor of class II (and class III) transcription in vivo, an activity conserved from yeast (Bur6/Ydr1) to human and genetically antagonistic to the SRB-MED (Mediator) holoenzyme [#1, #3, #14]. NC2 is bifunctional rather than purely repressive: it activates transcription from DPE-containing core promoters while repressing TATA-driven promoters, with these activities separable by mutation [#6], and it is required positively for a substantial fraction of genes, associating with active promoters in correlation with TBP occupancy [#10, #13]. Its repressive output is gated by signals and partners — induced by hypoxia to shut down preinitiation [#12], modulated by casein kinase II phosphorylation and glucose-dependent subunit association [#13], and tuned by interaction with BTAF1/Mot1, where NC2alpha specifically stimulates ATP-dependent BTAF1-TBP association [#15]. Beyond core transcription, DRAP1 restrains developmental signaling by binding and inhibiting DNA binding of the FoxH1 (FAST) transcription factor, thereby limiting the Nodal autoregulatory loop; its loss in mice causes severe gastrulation defects suppressible by Nodal heterozygosity [#11]. In triple-negative breast cancer, the DR1/DRAP1 complex represses CASTOR1 to activate mTOR signaling and drive tumor progression, with DRAP1 recruiting the deubiquitinase USP7 to stabilize DR1 [#21].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that DRAP1 is a corepressor that physically partners DR1 through a histone fold and acts on the basal transcription machinery, defining the molecular basis of repression.\",\n      \"evidence\": \"Biochemical purification from HeLa cells, in vitro transcription, and histone fold domain mutagenesis\",\n      \"pmids\": [\"8608938\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the atomic geometry of TBP contact\", \"Did not address positive/activating roles\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated that the DR1/DRAP1 (NC2) complex is a global, essential repressor acting by directly targeting TBP in vivo, and dissected which DR1 domains tether TBP versus repress.\",\n      \"evidence\": \"Yeast genetics (essential gene deletion, overexpression/TBP rescue) and reconstituted Pol II transcription with domain deletions\",\n      \"pmids\": [\"9023340\", \"8972183\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define DRAP1's own contribution to TBP contact independent of DR1\", \"Did not explain promoter-specific effects\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Placed NC2 in functional opposition to the Pol II holoenzyme by showing NC2 defects suppress SRB4 mutations, establishing it as a global negative regulator antagonizing Mediator.\",\n      \"evidence\": \"Genetic suppressor screen and in vivo mRNA synthesis measurement in yeast; systematic Bur6 histone-fold deletion analysis\",\n      \"pmids\": [\"9096360\", \"9121454\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of holoenzyme antagonism not biochemically reconstituted\", \"Promoter-context dependence not yet explained\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed NC2/DRAP1 is recruited as a corepressor by sequence-specific factors, linking the basal repressor to gene-specific regulation via direct AREB6 contact.\",\n      \"evidence\": \"In vitro transcription reconstitution and yeast two-hybrid with the AREB6 repression domain\",\n      \"pmids\": [\"9418848\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single corepressor relationship; generality across other factors untested\", \"In vivo relevance not established\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Revealed NC2 as bifunctional — activating DPE promoters while repressing TATA promoters — and that these are separable activities, overturning a purely repressive model.\",\n      \"evidence\": \"Purified recombinant Drosophila NC2 with DPE/TATA in vitro transcription and a separation-of-function mutant\",\n      \"pmids\": [\"11062130\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of DPE activation not defined\", \"Did not map DRAP1-specific residues for activation\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Connected NC2 to activated transcription and to the elongating polymerase, showing it is dispensable for basal but required for activated transcription and associates with hyperphosphorylated Pol IIO.\",\n      \"evidence\": \"Immunodepletion/rescue from HeLa extracts and co-IP with Pol II isoforms; complementary yeast sin4-bypass genetics\",\n      \"pmids\": [\"10852970\", \"10760173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect association with Pol IIO not resolved\", \"Did not identify the activated promoter determinants\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Localized DR1 repressor activity to its C-terminus and cemented genetic epistasis between the DR1-DRAP1 repressor and the SRB-MED complex.\",\n      \"evidence\": \"Yeast deletion mutagenesis, extragenic SIN4 suppressor screen, and SRB-MED biochemical analysis\",\n      \"pmids\": [\"10713169\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physical interface with Mediator not defined\", \"DRAP1-specific contribution not separated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Provided the atomic mechanism: the NC2alpha/NC2beta histone-fold heterodimer grips DNA under TBP and positions a helix to sterically block TFIIB.\",\n      \"evidence\": \"X-ray crystallography of the NC2-TBP-DNA ternary complex at 2.6 Å\",\n      \"pmids\": [\"11461703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Truncated NC2 omitted the C-terminal tails, missing the TFIIA-exclusion contact\", \"Static structure did not capture DPE-activation conformation\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed in vivo that NC2 occupancy tracks transcriptional activity genome-wide and can be positive or negative, reframing it as a context-dependent regulator of ~17% of genes.\",\n      \"evidence\": \"ChIP at yeast promoters with genome-wide transcription profiling\",\n      \"pmids\": [\"11283253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What determines positive vs negative outcome at a given promoter unresolved\", \"DRAP1 vs DR1 individual occupancy not separated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified an in vivo physiological role distinct from core transcription: DRAP1 binds and inhibits FoxH1 DNA binding to limit Nodal signaling during gastrulation.\",\n      \"evidence\": \"Mouse knockout with Nodal-heterozygosity suppression and biochemical FoxH1 DNA-binding inhibition assays\",\n      \"pmids\": [\"12471260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DR1 is required for FoxH1 inhibition not established\", \"Direct structural basis of FoxH1 contact unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined a signal-responsive repression mechanism: hypoxia raises NC2 levels to block preinitiation complex assembly and CTD phosphorylation at target promoters.\",\n      \"evidence\": \"Hypoxic extract reconstitution with immunodepletion rescue and PIC assembly assays\",\n      \"pmids\": [\"12477712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pathway linking hypoxia to NC2 induction not defined\", \"Target promoter selectivity not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed NC2 is a dynamically regulated complex — subunit association is glucose-dependent and CKII phosphorylation tunes repression — and that NC2alpha vs NC2beta occupancy predicts opposite outcomes.\",\n      \"evidence\": \"Conditional complex purification, ChIP, and CKII phosphosite mutagenesis in yeast\",\n      \"pmids\": [\"12502746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of free NC2alpha not fully defined\", \"CKII targets in mammalian DRAP1 not validated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Distinguished the two subunits functionally at the level of TBP-handling enzymes: NC2alpha (DRAP1) uniquely stimulates BTAF1/Mot1 ATP-dependent TBP association, whereas NC2beta antagonizes it.\",\n      \"evidence\": \"Reciprocal co-IP/pull-down with ATP manipulation and mutagenesis\",\n      \"pmids\": [\"15509807\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo significance of DRAP1-BTAF1 stimulation untested\", \"How this integrates with repression not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Refined NC2's gene-specific regulation of TFIIB recruitment and identified promoter elements (INR, ORF sequences) that dictate resistance or sensitivity to repression.\",\n      \"evidence\": \"In vitro transcription with promoter variants and TFIIA/TFIIB recruitment assays; NC2 mutant ChIP across genes\",\n      \"pmids\": [\"17584739\", \"18048413\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How ORF sequences feed back to promoter NC2 effect mechanistically unclear\", \"DRAP1-specific role in TFIIB control not isolated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Filled a structural gap by mapping a crystallographically invisible NC2alpha C-terminal tail–TBP helix-2 contact that explains TFIIA exclusion.\",\n      \"evidence\": \"Site-specific protein-protein photocrosslinking with crosslink mapping\",\n      \"pmids\": [\"18824481\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contact inferred from crosslinking, not high-resolution structure\", \"Functional necessity of this tail contact not separately tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed DRAP1 occupies Pol III (tRNA) templates but, unlike DR1, does not influence Pol III output, dissociating DRAP1 occupancy from function at these genes.\",\n      \"evidence\": \"ChIP and RNAi depletion with tRNA expression readout in human cells\",\n      \"pmids\": [\"19965767\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Why DRAP1 is present without functional effect unexplained\", \"Reciprocal DR1-independent DRAP1 roles untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended DRAP1 to disease mechanism: in TNBC the DR1/DRAP1 complex represses CASTOR1 to activate mTOR, with DRAP1 recruiting USP7 to stabilize DR1 in a feedback loop.\",\n      \"evidence\": \"Loss-of-function functional assays, in vivo tumor models, co-IP for USP7, and CASTOR1/mTOR mechanistic assays\",\n      \"pmids\": [\"38748783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CASTOR1 repression uses the canonical NC2-TBP mechanism not shown\", \"USP7 recruitment interface not mapped\", \"Single-lab single-cancer-context findings\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DRAP1 occupancy is translated into either activation or repression at a specific promoter, and the structural and signaling determinants that switch its bifunctional output, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking DPE activation to TATA repression at residue level\", \"Mammalian regulatory inputs (phosphorylation, partner switching) incompletely defined\", \"Generality of cancer-context CASTOR1/mTOR axis beyond TNBC unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 6, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 9, 15]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 10, 11]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [10, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 9, 10]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 21]}\n    ],\n    \"complexes\": [\n      \"NC2 (DR1-DRAP1) heterodimer\"\n    ],\n    \"partners\": [\n      \"DR1\",\n      \"TBP\",\n      \"BTAF1\",\n      \"FOXH1\",\n      \"USP7\",\n      \"AREB6\",\n      \"FEZ1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}